Ayurvedic Drug: Sitopaladi-Churna to Treat Lung Cancer

Sitopaladi-ChurnaSitopaladi Churna is an ayurvedic herbal formulation that helps lung cancer patients with their respiratory and digestive disorders. Browse through lungcancersymptomsx.com for more details:

Ayurveda for Lung Cancer

Sitopaladi Churna is an ayurvedic medicine beneficial in a variety of diseases relating to respiratory system, immune system and digestive system. It is one of the widely used Ayurvedic medicines for cough. As lung cancer patients often face respiratory issues, these ayurvedic herbs help to cure them. They offer a natural way to suppress the coughing of various lung diseases like asthma, tuberculosis, and pneumonia and lung cancer.

Health Benefits

It is an herbal formulation to balance the digestive disorders. It helps in curing cold, cough, asthma, bronchitis and sinusitis.  In addition to these benefits, it can also help in treating digestive fire, muscular cramps etc. Lung cancer patients find it effective in overcoming weakness and lethargy.

Ingredients and Dosage

The main ingredients of Sitopaladi Churna is sugar candy powder, cardamom, cinnamon, long pepper and inner white light part of bamboo tree. The fine herbal powders of these herbs are mixed thoroughly and stored in a tight container. As far as the dosage is concerned, it is usually given in varied dose of one to three grams and two or three times a day.

Cautions

Though Sitopaladi Churna is considered safe, but it should always be taken after consultation with the doctor. It may not be suitable for people with diabetes. It can be taken by lung cancer patients but is not meant for symptomatic relief. You should continue your lung cancer treatment and can ask your doctor to include ayurvedic medicines, if he finds them effective for you.

Share your thoughts about the cure of lung cancer in ayurveda with us in the comments section below.

 

The information shared here is for educational purposes only and is certainly not a substitute for medical advice.

Leave a Reply